Scientists are now investigating whether GLP-1 drugs could help treat substance use disorders, which also involve dopamine-driven reward pathways
Practice Point 4.3.3: GLP-1 RA should not be used in combination with DPP-4 inhibitors
The review also identifies gaps in knowledge, suggesting future research directions for optimizing patient selection and treatment regimens to maximize therapeutic benefits
These effects have been consistently observed across commonly used GLP-1RAs, including semaglutide and liraglutide
GLP-1-related hair loss is called telogen effluvium, which causes sudden, diffuse shedding usually temporary
For more significant symptoms, low-dose vaginal estrogen creams or rings, which act locally rather than systemically, can restore vaginal tissue health without significantly affecting blood estrogen levels